Seres Therapeutics, Inc. (MCRB)
NASDAQ: MCRB · Real-Time Price · USD
0.887
-0.037 (-4.04%)
At close: Dec 27, 2024, 4:00 PM
0.890
+0.003 (0.36%)
After-hours: Dec 27, 2024, 5:41 PM EST
Seres Therapeutics Market Cap
Seres Therapeutics has a market cap or net worth of $151.41 million as of December 27, 2024. Its market cap has increased by 11.58% in one year.
Market Cap
151.41M
Enterprise Value
178.20M
1-Year Change
11.58%
Ranking
Category
Stock Price
$0.89
Market Cap Chart
Since June 26, 2015, Seres Therapeutics's market cap has decreased from $1.88B to $151.41M, a decrease of -91.96%. That is a compound annual growth rate of -23.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 27, 2024 | 151.40M | -16.35% |
| Dec 29, 2023 | 181.00M | -74.06% |
| Dec 30, 2022 | 697.70M | -8.81% |
| Dec 31, 2021 | 765.10M | -65.78% |
| Dec 31, 2020 | 2.24B | 825.71% |
| Dec 31, 2019 | 241.50M | 30.75% |
| Dec 31, 2018 | 184.70M | -55.06% |
| Dec 29, 2017 | 411.00M | 2.88% |
| Dec 30, 2016 | 399.50M | -70.85% |
| Dec 31, 2015 | 1.37B | -27.26% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innate Pharma | 161.48M |
| Aligos Therapeutics | 160.79M |
| Pro-Dex | 160.20M |
| Sutro Biopharma | 159.56M |
| Corbus Pharmaceuticals Holdings | 159.55M |
| Greenwich LifeSciences | 157.21M |
| EUDA Health Holdings | 156.92M |
| 2seventy bio | 155.80M |